Genetic mutations can be benign or cancerous – a new method to differentiate between them could lead to better treatments
Ryan Layer, University of Colorado Boulder Most of the roughly 40 trillion cells of your…
Browsing: Featured
ASCO 2022: Next-generation immunotherapy drug shows continued promise in several advanced-stage cancers
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or…
ASCO 2022: Patient-facing screening tool could increase detection of individuals with inherited cancer risk
Nearly one million people in the United States are affected by Lynch syndrome – a…
The paired perils of breast cancer and diabetes
Breast cancer and type 2 diabetes would seem to be distinctly different diseases, with commonality…
Men with prostate cancer have a higher risk of serious blood clots
New research published in the online journal BMJ Open suggests that men with prostate cancer have a…
How machine learning is helping patients diagnosed with ALL
New software developed by Peter Mac and collaborators is helping patients diagnosed with acute lymphoblastic…
Preliminary study shows minimally invasive diagnostic biomarker strategy successful in detecting early oesophageal cancer
In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally…
Adolescent and young adult leukaemia survivors face higher mortality rates for decades after diagnosis
The long-term survival of adolescent and young adult (AYA) acute myeloid leukaemia (AML) and acute…
Density, benign disease raise risk of breast cancer
Women with dense breast tissue and benign breast disease face an elevated risk of future…
Early days of COVID-19 pandemic brought increased anxiety for some cancer survivors
Among the many lessons collectively learned during the initial months of the worldwide COVID-19 pandemic…